Reviews |
From Osiris Therapeutics, Inc., Baltimore, Md.
Correspondence to Mark F. Pittenger, PhD, Osiris Therapeutics, Inc., 2001 Aliceanna St, Baltimore, MD 21231. E-mail mpittenger{at}osiristx.com
This Review is part of a thematic series on Stem Cells, which includes the following articles:
Differentiation of Pluripotent Embryonic Stem Cells Into Cardiomyocytes
Derivation and Potential Applications of Human Embryonic Stem Cells
Stem Cells for Myocardial Regeneration
Myocyte Death, Growth, and Regeneration in Cardiac Hypertrophy and Failure
Neural Stem Cells: An Overview
Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics
Therapeutics and Use of Stem Cells
Roberto Bolli Editors
Mesenchymal stem cells (MSCs) represent a stem cell population present in adult tissues that can be isolated, expanded in culture, and characterized in vitro and in vivo. MSCs differentiate readily into chondrocytes, adipocytes, osteocytes, and they can support hematopoietic stem cells or embryonic stem cells in culture. Evidence suggests MSCs can also express phenotypic characteristics of endothelial, neural, smooth muscle, skeletal myoblasts, and cardiac myocyte cells. When introduced into the infarcted heart, MSCs prevent deleterious remodeling and improve recovery, although further understanding of MSC differentiation in the cardiac scar tissue is still needed. MSCs have been injected directly into the infarct, or they have been administered intravenously and seen to home to the site of injury. Examination of the interaction of allogeneic MSCs with cells of the immune system indicates little rejection by T cells. Persistence of allogeneic MSCs in vivo suggests their potential "off the shelf" therapeutic use for multiple recipients. Clinical use of cultured human MSCs (hMSCs) has begun for cancer patients, and recipients have received autologous or allogeneic MSCs. Research continues to support the desirable traits of MSCs for development of cellular therapeutics for many tissues, including the cardiovascular system. In summary, hMSCs isolated from adult bone marrow provide an excellent model for development of stem cell therapeutics, and their potential use in the cardiovascular system is currently under investigation in the laboratory and clinical settings.
Key Words: cardiomyoplasty mesenchymal cell therapy stem cell
This article has been cited by other articles:
![]() |
R. Abdi, P. Fiorina, C. N. Adra, M. Atkinson, and M. H. Sayegh Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes Diabetes, July 1, 2008; 57(7): 1759 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Coutu, J. H. Wu, A. Monette, G.-E. Rivard, M. D. Blostein, and J. Galipeau Periostin, a Member of a Novel Family of Vitamin K-dependent Proteins, Is Expressed by Mesenchymal Stromal Cells J. Biol. Chem., June 27, 2008; 283(26): 17991 - 18001. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Kalka and I. Baumgartner Gene and stem cell therapy in peripheral arterial occlusive disease Vascular Medicine, May 1, 2008; 13(2): 157 - 172. [Abstract] [PDF] |
||||
![]() |
M. P. Flaherty, A. Abdel-Latif, Q. Li, G. Hunt, S. Ranjan, Q. Ou, X.-L. Tang, R. K. Johnson, R. Bolli, and B. Dawn Noncanonical Wnt11 Signaling Is Sufficient to Induce Cardiomyogenic Differentiation in Unfractionated Bone Marrow Mononuclear Cells Circulation, April 29, 2008; 117(17): 2241 - 2252. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Grauss, J. van Tuyn, P. Steendijk, E. M. Winter, D. A. Pijnappels, B. Hogers, A. C. Gittenberger-De Groot, R. van der Geest, A. van der Laarse, A. A.F. de Vries, et al. Forced Myocardin Expression Enhances the Therapeutic Effect of Human Mesenchymal Stem Cells After Transplantation in Ischemic Mouse Hearts Stem Cells, April 1, 2008; 26(4): 1083 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hess, T. P. Craft, L. Wirthlin, S. Hohm, P. Zhou, W. C. Eades, M. H. Creer, M. S. Sands, and J. A. Nolta Widespread Nonhematopoietic Tissue Distribution by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity Stem Cells, March 1, 2008; 26(3): 611 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Beltrami Life is plastic Blood, March 1, 2008; 111(5): 2942 - 2943. [Full Text] [PDF] |
||||
![]() |
U. Lakshmipathy and R. P. Hart Concise Review: MicroRNA Expression in Multipotent Mesenchymal Stromal Cells Stem Cells, February 1, 2008; 26(2): 356 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jones and D. McGonagle Human bone marrow mesenchymal stem cells in vivo Rheumatology, February 1, 2008; 47(2): 126 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shujia, H. K. Haider, N. M. Idris, G. Lu, and M. Ashraf Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair Cardiovasc Res, February 1, 2008; 77(3): 525 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Selmani, A. Naji, I. Zidi, B. Favier, E. Gaiffe, L. Obert, C. Borg, P. Saas, P. Tiberghien, N. Rouas-Freiss, et al. Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells Stem Cells, January 1, 2008; 26(1): 212 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, P. Song, Y. Tang, X.-l. Zhang, S.-h. Zhao, Y.-j. Wei, and S.-s. Hu Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1234 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Karnieli, Y. Izhar-Prato, S. Bulvik, and S. Efrat Generation of Insulin-Producing Cells from Human Bone Marrow Mesenchymal Stem Cells by Genetic Manipulation Stem Cells, November 1, 2007; 25(11): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Beltrami, D. Cesselli, N. Bergamin, P. Marcon, S. Rigo, E. Puppato, F. D'Aurizio, R. Verardo, S. Piazza, A. Pignatelli, et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow) Blood, November 1, 2007; 110(9): 3438 - 3446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. English, E. A. Jones, D. Corscadden, K. Henshaw, T. Chapman, P. Emery, and D. McGonagle A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis Rheumatology, November 1, 2007; 46(11): 1676 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Simpson, H. Liu, T.-H. M. Fan, R. Nerem, and S. C. Dudley Jr. A Tissue Engineering Approach to Progenitor Cell Delivery Results in Significant Cell Engraftment and Improved Myocardial Remodeling Stem Cells, September 1, 2007; 25(9): 2350 - 2357. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Breitbach, T. Bostani, W. Roell, Y. Xia, O. Dewald, J. M. Nygren, J. W. U. Fries, K. Tiemann, H. Bohlen, J. Hescheler, et al. Potential risks of bone marrow cell transplantation into infarcted hearts Blood, August 15, 2007; 110(4): 1362 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vincentelli, F. Wautot, F. Juthier, O. Fouquet, D. Corseaux, S. Marechaux, T. Le Tourneau, O. Fabre, S. Susen, E. Van Belle, et al. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates? J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 424 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, N. Ma, L.-L. Ong, C. Nesselmann, C. Klopsch, Y. Ladilov, D. Furlani, C. Piechaczek, J. M. Moebius, K. Lutzow, et al. Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function Stem Cells, August 1, 2007; 25(8): 2118 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schafer, R. Kehlbach, J. Wiskirchen, R. Bantleon, J. Pintaske, B. R. Brehm, A. Gerber, H. Wolburg, C. D. Claussen, and H. Northoff Transferrin Receptor Upregulation: In Vitro Labeling of Rat Mesenchymal Stem Cells with Superparamagnetic Iron Oxide Radiology, August 1, 2007; 244(2): 514 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ip, Y. Wu, J. Huang, L. Zhang, R. E. Pratt, and V. J. Dzau Mesenchymal Stem Cells Use Integrin beta1 Not CXC Chemokine Receptor 4 for Myocardial Migration and Engraftment Mol. Biol. Cell, August 1, 2007; 18(8): 2873 - 2882. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shi, J. Li, L. Liao, B. Chen, B. Li, L. Chen, H. Jia, and R. C. Zhao Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice Haematologica, July 1, 2007; 92(7): 897 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao and S. Ding A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cells PNAS, June 5, 2007; 104(23): 9673 - 9678. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Schweizer, U. Krause, R. Becker, A. Seckinger, A. Bauer, C. Hardt, V. Eckstein, A. D. Ho, M. Koenen, H. A. Katus, et al. Atrial-Radiofrequency Catheter Ablation Mediated Targeting of Mesenchymal Stromal Cells Stem Cells, June 1, 2007; 25(6): 1546 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tateishi, E. Ashihara, N. Takehara, T. Nomura, S. Honsho, T. Nakagami, S. Morikawa, T. Takahashi, T. Ueyama, H. Matsubara, et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration J. Cell Sci., May 15, 2007; 120(10): 1791 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ventura, S. Cantoni, F. Bianchi, V. Lionetti, C. Cavallini, I. Scarlata, L. Foroni, M. Maioli, L. Bonsi, F. Alviano, et al. Hyaluronan Mixed Esters of Butyric and Retinoic Acid Drive Cardiac and Endothelial Fate in Term Placenta Human Mesenchymal Stem Cells and Enhance Cardiac Repair in Infarcted Rat Hearts J. Biol. Chem., May 11, 2007; 282(19): 14243 - 14252. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Fan, A. Au, K. Tamama, R. Littrell, L. B. Richardson, J. W. Wright, A. Wells, and L. G. Griffith Tethered Epidermal Growth Factor Provides a Survival Advantage to Mesenchymal Stem Cells Stem Cells, May 1, 2007; 25(5): 1241 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohnishi, T. Yasuda, S. Kitamura, and N. Nagaya Effect of Hypoxia on Gene Expression of Bone Marrow-Derived Mesenchymal Stem Cells and Mononuclear Cells Stem Cells, May 1, 2007; 25(5): 1166 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Muller-Borer, W. E. Cascio, G. L. Esch, H.-S. Kim, W. B. Coleman, J. W. Grisham, P. A. W. Anderson, and N. N. Malouf Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells PNAS, March 6, 2007; 104(10): 3877 - 3882. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dawn and R. Bolli Bone marrow for cardiac repair: the importance of characterizing the phenotype and function of injected cells Eur. Heart J., March 5, 2007; (2007) ehm009v1. [Full Text] [PDF] |
||||
![]() |
E. J. Gang, D. Bosnakovski, C. A. Figueiredo, J. W. Visser, and R. C. R. Perlingeiro SSEA-4 identifies mesenchymal stem cells from bone marrow Blood, February 15, 2007; 109(4): 1743 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K.S. Chong, A. D. Ang, J. C.H. Goh, J. H.P. Hui, A. Y.T. Lim, E. H. Lee, and B. H. Lim Bone Marrow-Derived Mesenchymal Stem Cells Influence Early Tendon-Healing in a Rabbit Achilles Tendon Model J. Bone Joint Surg. Am., January 1, 2007; 89(1): 74 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bruno, B. Bussolati, C. Grange, F. Collino, M. E. Graziano, U. Ferrando, and G. Camussi CD133+ Renal Progenitor Cells Contribute to Tumor Angiogenesis Am. J. Pathol., December 1, 2006; 169(6): 2223 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. F. Zhou, M. Bosch-Marce, H. Okuyama, B. Krishnamachary, H. Kimura, L. Zhang, D. L. Huso, and G. L. Semenza Spontaneous Transformation of Cultured Mouse Bone Marrow-Derived Stromal Cells. Cancer Res., November 15, 2006; 66(22): 10849 - 10854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zeng, E. Rahrmann, Q. Hu, T. Lund, L. Sandquist, M. Felten, T. D. O'Brien, J. Zhang, and C. Verfaillie Multipotent Adult Progenitor Cells from Swine Bone Marrow Stem Cells, November 1, 2006; 24(11): 2355 - 2366. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Pijnappels, M. J. Schalij, J. van Tuyn, D. L. Ypey, A. A.F. de Vries, E. E. van der Wall, A. van der Laarse, and D. E. Atsma Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling Cardiovasc Res, November 1, 2006; 72(2): 282 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-L. Ang, L. Takura Shenje, L. Srinivasan, and M. Galinanes Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope. Ann. Thorac. Surg., October 1, 2006; 82(4): 1549 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-T. Guo, R. SchAfer, A. Paul, A. Gerber, G. Ziemer, and H. P. Wendel A New Technique for the Isolation and Surface Immobilization of Mesenchymal Stem Cells from Whole Bone Marrow Using High-Specific DNA Aptamers Stem Cells, October 1, 2006; 24(10): 2220 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jiang, H. Kh. Haider, N. M. Idris, A. Salim, and M. Ashraf Supportive Interaction Between Cell Survival Signaling and Angiocompetent Factors Enhances Donor Cell Survival and Promotes Angiomyogenesis for Cardiac Repair Circ. Res., September 29, 2006; 99(7): 776 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zeng, Q. Xiao, A. Margariti, Z. Zhang, A. Zampetaki, S. Patel, M. C. Capogrossi, Y. Hu, and Q. Xu HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells J. Cell Biol., September 25, 2006; 174(7): 1059 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Martens, M. Argenziano, and M. C. Oz New Technology for Surgical Coronary Revascularization Circulation, August 8, 2006; 114(6): 606 - 614. [Full Text] [PDF] |
||||
![]() |
E. N. Olivier, A. C. Rybicki, and E. E. Bouhassira Differentiation of Human Embryonic Stem Cells into Bipotent Mesenchymal Stem Cells Stem Cells, August 1, 2006; 24(8): 1914 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Boyle, S. P. Schulman, and J. M. Hare Stem Cell Therapy for Cardiac Repair: Ready for the Next Step Circulation, July 25, 2006; 114(4): 339 - 352. [Full Text] [PDF] |
||||
![]() |
P. Oettgen Cardiac Stem Cell Therapy: Need for Optimization of Efficacy and Safety Monitoring Circulation, July 25, 2006; 114(4): 353 - 358. [Full Text] [PDF] |
||||
![]() |
M. Hendrikx, K. Hensen, C. Clijsters, H. Jongen, R. Koninckx, E. Bijnens, M. Ingels, A. Jacobs, R. Geukens, P. Dendale, et al. Recovery of Regional but Not Global Contractile Function by the Direct Intramyocardial Autologous Bone Marrow Transplantation: Results From a Randomized Controlled Clinical Trial Circulation, July 4, 2006; 114(1_suppl): I-101 - I-107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmidt, D. Ladage, T. Schinkothe, U. Klausmann, C. Ulrichs, F.-J. Klinz, K. Brixius, S. Arnhold, B. Desai, U. Mehlhorn, et al. Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells Stem Cells, July 1, 2006; 24(7): 1750 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okuyama, B. Krishnamachary, Y. F. Zhou, H. Nagasawa, M. Bosch-Marce, and G. L. Semenza Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1 J. Biol. Chem., June 2, 2006; 281(22): 15554 - 15563. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Wang, H E Johnsen, S Mortensen, L Bindslev, R Sejersten Ripa, M Haack-Sorensen, E Jorgensen, W Fang, and J Kastrup Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention Heart, June 1, 2006; 92(6): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Khakoo, S. Pati, S. A. Anderson, W. Reid, M. F. Elshal, I. I. Rovira, A. T. Nguyen, D. Malide, C. A. Combs, G. Hall, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma J. Exp. Med., May 15, 2006; 203(5): 1235 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murry, H. Reinecke, and L. M. Pabon Regeneration Gaps: Observations on Stem Cells and Cardiac Repair J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Freyman, G. Polin, H. Osman, J. Crary, M. Lu, L. Cheng, M. Palasis, and R. L. Wilensky A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Eur. Heart J., May 1, 2006; 27(9): 1114 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zentilin, S. Tafuro, S. Zacchigna, N. Arsic, L. Pattarini, M. Sinigaglia, and M. Giacca Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels Blood, May 1, 2006; 107(9): 3546 - 3554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuda and S. Yuasa Stem Cells as a Source of Regenerative Cardiomyocytes Circ. Res., April 28, 2006; 98(8): 1002 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gnecchi, H. He, N. Noiseux, O. D. Liang, L. Zhang, F. Morello, H. Mu, L. G. Melo, R. E. Pratt, J. S. Ingwall, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J, April 1, 2006; 20(6): 661 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Simmons, B. Short, and N. Brouard The Properties of Prospectively Isolated Mesenchymal Stem Cells from Man and Mouse Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 334 - 338. [Full Text] [PDF] |
||||
![]() |
|